Tuesday - September 9, 2025
Adding Niraparib to Standard Treatment May Slow Cancer Growth for Some Patients With Metastatic Castration-Sensitive Prostate Cancer
June 04, 2025
ALEXANDRIA, Virginia, June 4 -- The American Society of Clinical Oncology posted the following news release:

* * *

Adding Niraparib to Standard Treatment May Slow Cancer Growth for Some Patients With Metastatic Castration-Sensitive Prostate Cancer

ASCO Perspective Quote

"This trial emphasizes the importance of germline and somatic testing in patients with metastatic prostate cancer at the time of diagnosis; homologous recombination repair . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products